Page last updated: 2024-09-03

sch 42495 and Ventricular Dysfunction, Left

sch 42495 has been researched along with Ventricular Dysfunction, Left in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Espiner, EA; Lainchbury, JG; Nicholls, MG; Richards, AM; Yandle, TG	1

Trials

1 trial(s) available for sch 42495 and Ventricular Dysfunction, Left

Article	Year
Brain natriuretic peptide and neutral endopeptidase inhibition in left ventricular impairment. The Journal of clinical endocrinology and metabolism, 1999, Volume: 84, Issue:2 Topics: Adult; Aged; Aldosterone; Blood Pressure; Cyclic GMP; Drug Synergism; Humans; Male; Metabolic Clearance Rate; Methionine; Middle Aged; Natriuresis; Natriuretic Peptide, Brain; Neprilysin; Protease Inhibitors; Renin; Ventricular Dysfunction, Left	1999

Article

Year

Brain natriuretic peptide and neutral endopeptidase inhibition in left ventricular impairment.

The Journal of clinical endocrinology and metabolism, 1999, Volume: 84, Issue:2

Topics: Adult; Aged; Aldosterone; Blood Pressure; Cyclic GMP; Drug Synergism; Humans; Male; Metabolic Clearance Rate; Methionine; Middle Aged; Natriuresis; Natriuretic Peptide, Brain; Neprilysin; Protease Inhibitors; Renin; Ventricular Dysfunction, Left

1999